Developing a long term strategy to shift or diversify global supply chains can position manufacturers for growth and resiliency.
Global manufacturing supply chains have been hit on multiple fronts, with production across the globe severely impacted by full shut-downs coupled with disrupted distribution channels from border closures, loss of air cargo capacity, and even driver shortages.
Global business support measures have been put in place by various jurisdictions in response to the sharp downturn resulting from the COVID-19 crisis. Understanding the key issues global manufacturers are facing, as well as designing and implementing a strategic action plan can help prepare you to survive and ultimately outperform competitors.
The purpose of this document is to broadly analyze the impact of these measures and other planning opportunities on global manufacturing and supply chain sectors, two of the most affected by the COVID-19 crisis.
Manufacturing Analysis: Key Country Considerations
Please see our separate industry report for implications on the technology/Software as a Service (SaaS) industry. Found HERE.
See Al Liguori’s interview with Supply Chain Brain on How Businesses Can Reset for the ‘New Normal’. Found HERE.
Financing Saudi Arabia’s Data Center Build-Out
August 6, 2026
Discover financing strategies for Saudi Arabia's data center build-out, from bankability and project finance to capital structuring and debt advisory.
Section 232 Pharmaceutical Duties: UK Rate Cut to Zero, and the Origin and Section 301 Questions That Follow
August 5, 2026
Effective July 31, 2026, the additional Section 232 tariff on patented pharmaceuticals that are products of the United Kingdom was reduced from 10% to zero (heading 9903.04.63), implementing the U.S.–UK Pharmaceutical Pricing Arrangement. Because UK patented pharmaceuticals remain subject to Section 232 (at a 0% rate), they also fall within the Section 232 carve-out from the new Section 301 forced labor tariffs — so qualifying UK patented product should face no additional duty under either regime.
Enterprise Management Incentive Plans - Recent Changes and Common Pitfalls
August 5, 2026
Enterprise Management Incentive (EMI) option plans have been at the centre of UK employee incentivisation for many years and remain popular with privately owned, fast-growing companies.
Better Data, Better Exits: The New Playbook for Wealth and Insurance Platform Roll-Ups
August 5, 2026
There’s a new value creation imperative for private equity (PE) firms and corporates seeking to roll up financial technology (FinTech) and data platform acquisitions, especially in the extended higher interest rate environment. Many of the traditional value enhancement strategies still matter, but operational platforming—integrating tech, data, and systems—can be a defining competitive advantage in roll-ups.
